An open-label, multicenter, phase II trial of nab-paclitaxel (NP) versus dacarbazine (DTIC) in previously untreated patients (PTs) with metastatic malignant melanoma (MMM)

E. Hersh, M. Millward, I. Elias, J. Iglesias

Research output: Contribution to journalAbstract/Meeting Abstractpeer-review

3 Citations (Web of Science)
Original languageEnglish
Number of pages1
JournalJournal of Clinical Oncology
Volume28
Issue number15
DOIs
Publication statusPublished - 20 May 2010
Externally publishedYes

Cite this